These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 23950216)

  • 1. Fecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test.
    Koga Y; Yamazaki N; Yamamoto Y; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
    Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1844-52. PubMed ID: 23950216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the fecal microRNA test to the residuum from the fecal occult blood test.
    Yamazaki N; Koga Y; Yamamoto S; Kakugawa Y; Otake Y; Hayashi R; Saito N; Matsumura Y
    Jpn J Clin Oncol; 2013 Jul; 43(7):726-33. PubMed ID: 23677957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
    Luo X; Wu Y; Ji M; Zhang S
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
    Koga Y; Yasunaga M; Takahashi A; Kuroda J; Moriya Y; Akasu T; Fujita S; Yamamoto S; Baba H; Matsumura Y
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1435-42. PubMed ID: 20959518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
    Lohsiriwat V; Thavichaigarn P; Awapittaya B
    J Med Assoc Thai; 2007 Nov; 90(11):2291-5. PubMed ID: 18181309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal DNA for noninvasive diagnosis of colorectal cancer in immunochemical fecal occult blood test-positive individuals.
    Calistri D; Rengucci C; Casadei Gardini A; Frassineti GL; Scarpi E; Zoli W; Falcini F; Silvestrini R; Amadori D
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2647-54. PubMed ID: 20929882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
    Takai T; Kanaoka S; Yoshida K; Hamaya Y; Ikuma M; Miura N; Sugimura H; Kajimura M; Hishida A
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1888-93. PubMed ID: 19505922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer screening: comparison of transferrin and immuno fecal occult blood test.
    Chen JG; Cai J; Wu HL; Xu H; Zhang YX; Chen C; Wang Q; Xu J; Yuan XL
    World J Gastroenterol; 2012 Jun; 18(21):2682-8. PubMed ID: 22690078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers.
    Karl J; Wild N; Tacke M; Andres H; Garczarek U; Rollinger W; Zolg W
    Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1122-8. PubMed ID: 18928937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal cytology in conjunction with immunofecal occult blood test for colorectal cancer screening.
    Sheng JQ; Li SR; Su H; Li JS; Sun ZQ; Wu ZT; Wu X; Xia CH; Rao J
    Anal Quant Cytol Histol; 2010 Jun; 32(3):131-5. PubMed ID: 20701065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transferrin dipstick as a potential novel test for colon cancer screening: a comparative study with immuno fecal occult blood test.
    Sheng JQ; Li SR; Wu ZT; Xia CH; Wu X; Chen J; Rao J
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2182-5. PubMed ID: 19661074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
    Oono Y; Iriguchi Y; Doi Y; Tomino Y; Kishi D; Oda J; Takayanagi S; Mizutani M; Fujisaki T; Yamamura A; Hosoi T; Taguchi H; Kosaka M; Delgado P
    Clin Chim Acta; 2010 Jun; 411(11-12):802-5. PubMed ID: 20184867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of plasma miR-106a in colorectal cancer and its clinical significance].
    Zhang L; Meng L; Fan Z; Liu B; Pei Y; Zhao Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):354-7. PubMed ID: 24670448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of fecal miR-143 and miR-145 as potential markers for colorectal cancer.
    Li JM; Zhao RH; Li ST; Xie CX; Jiang HH; Ding WJ; Du P; Chen W; Yang M; Cui L
    Saudi Med J; 2012 Jan; 33(1):24-9. PubMed ID: 22273643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression analysis using a highly sensitive DNA microarray for colorectal cancer screening.
    Koga Y; Yamazaki N; Takizawa S; Kawauchi J; Nomura O; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
    Anticancer Res; 2014 Jan; 34(1):169-76. PubMed ID: 24403458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening.
    van Rossum LG; van Rijn AF; van Oijen MG; Fockens P; Laheij RJ; Verbeek AL; Jansen JB; Dekker E
    Int J Cancer; 2009 Aug; 125(4):746-50. PubMed ID: 19408302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive screening tests for colorectal cancer.
    Imperiale TF
    Dig Dis; 2012; 30 Suppl 2():16-26. PubMed ID: 23207928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
    Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of serum markers for the early detection of colorectal cancer.
    Wild N; Andres H; Rollinger W; Krause F; Dilba P; Tacke M; Karl J
    Clin Cancer Res; 2010 Dec; 16(24):6111-21. PubMed ID: 20798228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.